The second leg of Ayodhya Pran Pratishtha is set to begin in Uttar Pradesh on Monday. More than 1.5 years after the ...

Carey: I am going to go for a strike that was almost the goal of the competition. Barely 90 seconds after Lamine Yamal curled in the outrageous effort into the far corner for Barcelona in their ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Two singers in the Tabernacle Choir — one who is just beginning and a one-year member — share their experiences with the four ...

Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to a State ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

What is Loud? A Web3 experiment on Solana that turns social attention into tradable value through the $LOUD token and ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

One of the toughest challenges in the base campaign of Xenoblade Chronicles X might just be the intimidating boss of Chapter ...